How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study.
Magro F, Estevinho MM, Catalano G, Patita M, Arroja B, Lago P, Rosa I, Tavares de Sousa H, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Sousa P, Portela F, Correia L, Moreira P, Santiago M, Dias S, Afonso J, Danese S, Peyrin-Biroulet L, Dias CC; GEDII (Grupo de Estudos da Doença Inflamatória Intestinal).
Magro F, et al. Among authors: portela f.
United European Gastroenterol J. 2023 Jul;11(6):531-541. doi: 10.1002/ueg2.12420. Epub 2023 Jun 15.
United European Gastroenterol J. 2023.
PMID: 37318072
Free PMC article.